Next Article in Journal
Adverse Reactions to Evolocumab: Analysis of Real-World Data from EudraVigilance
Previous Article in Journal
Sodium Glucose Cotransporter-2 Inhibitors in Non-Diabetic Kidney Disease: Evidence in Experimental Models
 
 
Article

Article Versions Notes

Pharmaceuticals 2024, 17(3), 363; https://doi.org/10.3390/ph17030363
Action Date Notes Link
article html file updated 25 June 2025 16:19 CEST Update https://www.mdpi.com/1424-8247/17/3/363/html
article html file updated 11 March 2024 11:42 CET Original file -
article supplementary file uploaded. 11 March 2024 11:40 CET - https://www.mdpi.com/1424-8247/17/3/363#supplementary
article pdf uploaded. 11 March 2024 11:40 CET Version of Record https://www.mdpi.com/1424-8247/17/3/363/pdf
article xml uploaded. 11 March 2024 11:40 CET Update https://www.mdpi.com/1424-8247/17/3/363/xml
article xml file uploaded 11 March 2024 11:40 CET Original file -
Back to TopTop